Concepedia

Shrijal S. Shah

SS

9

Publications

757

Citations

9

H-Index

2014

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Baylor College of Medicine

Broad Institute

Dan L Duncan Comprehensive Cancer Center

Shrijal S. Shah is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

2014–2022

9

Publications

9

Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer

Chuandong Geng, Kimal Rajapakshe, Shrijal S. Shah et al. · Cancer Research · 2014 · 192 citations · Full text

GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex

Bin He, Rainer B. Lanz, Warren Fiskus et al. · Proceedings of the National Academy of Sciences · 2014 · 127 citations · Full text

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein

Chong Geng, Salma Kaochar, M. Li et al. · Oncogene · 2017 · 127 citations · Full text

, , +10

APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore

Shrijal S. Shah, Herbert Lannon, Leny Dias et al. · Journal of the American Society of Nephrology · 2019 · 88 citations · Full text

Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background

Herbert Lannon, Shrijal S. Shah, Leny Dias et al. · Kidney International · 2019 · 66 citations · Full text

, , +10

Rows per page

1–5 of 9